USA flag logo/image

An Official Website of the United States Government

Xenogeneic Arterial Bypass Graft

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
29497
Program Year/Program:
1995 / SBIR
Agency Tracking Number:
29497
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
CRYOLIFE, INC.
1655 ROBERTS BLVD, NW KENNESAW, GA 30144
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1995
Title: Xenogeneic Arterial Bypass Graft
Agency: HHS
Contract: 1 R43 HL53192-01,
Award Amount: $73,360.00
 

Abstract:

Although the autogenous saphenous vein is the vessel typically utilized in arterial bypass procedurarise in which it is not possible to use this vein, demanding an alternative method. The investigatofeasibility study in canine subjects to determine whether an immunologically modified xenogeneic vesendothelium can serve as a replacement of the autogenous saphenous vein. The investigators intend tothe tissue modification technique, and seek to optimize endothelial cell seeding. The final object oassess in vivo the biocompatibility of the implant, as well as its overall effectiveness as a graft.

Principal Investigator:

Steven Goldstein
40452

Business Contact:

Small Business Information at Submission:

Cryolife, Inc.
2211 New Market Parkway, Suite Marietta, GA 30067

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No